FARMAK, a.s. focused on nuclear magnetic resonance in the study of small molecules
We expect a significant breakthrough in the field of ophthalmology
FARMAK, a.s. supports innovative research and actively collaborates on scientific projects
The final part of ‘History Sneak Peek’
Pharmaceutical newcomers of 2022
The rule of `quality is more important than quantity` applies in pharmacy too
Glaucoma - A Silent Sight Killer
Back to history - Construction of the Year 2004
Open Day - 30 years of FARMAK, a.s.
Will Rho kinase inhibitors help to prevent vision loss caused by glaucoma?